- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 13, 2011
Product Development
Exelixis makes its case
Exelixis argues for novel Phase III strategy for cabozantinib in prostate cancer
BioCentury | Jan 3, 2011
Product Development
Third time even better
Bone mets data for Amgen's Xgeva look transformational for prostate oncologists
BioCentury | Nov 22, 2010
Product Development
Full Speed Ahead
Bone metastases and beyond: What's next in Amgen's timetable for denosumab
Items per page:
1 - 10 of 84